Total Payments
$8,814
2024 Payments
$2,281
Companies
43
Transactions
568
Medicare Patients
4,271
Medicare Billing
$248,212
Payment Breakdown by Category
Food & Beverage$8,811 (100.0%)
Education$3.31 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,811 | 567 | 100.0% |
| Education | $3.31 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,312 | 65 | $0 (2024) |
| ABBVIE INC. | $1,214 | 90 | $0 (2024) |
| Novo Nordisk Inc | $978.73 | 73 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $680.46 | 47 | $0 (2024) |
| Lilly USA, LLC | $680.21 | 44 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $536.39 | 27 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $394.46 | 23 | $0 (2024) |
| ITI, Inc. | $308.38 | 20 | $0 (2023) |
| EISAI INC. | $253.85 | 23 | $0 (2022) |
| GlaxoSmithKline, LLC. | $213.23 | 18 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,281 | 117 | AstraZeneca Pharmaceuticals LP ($456.74) |
| 2023 | $2,180 | 139 | ABBVIE INC. ($323.59) |
| 2022 | $2,180 | 144 | AstraZeneca Pharmaceuticals LP ($322.11) |
| 2021 | $2,173 | 168 | AbbVie Inc. ($349.58) |
All Payment Transactions
568 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Gastroenterology | ||||||
| 10/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Central Nervous System | ||||||
| 10/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Cardio-renal | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.46 | General |
| 09/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/24/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardio-renal | ||||||
| 09/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/04/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.36 | General |
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 817 | 1,632 | $142,063 | $43,886 |
| 2022 | 21 | 1,043 | 2,524 | $156,399 | $58,045 |
| 2021 | 23 | 1,248 | 2,819 | $196,924 | $75,924 |
| 2020 | 25 | 1,163 | 3,076 | $201,724 | $70,357 |
Total Patients
4,271
Total Services
10,051
Medicare Billing
$248,212
Procedure Codes
89
All Medicare Procedures & Services
89 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 229 | $51,525 | $16,385 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 257 | $44,975 | $11,891 | 26.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 70 | 70 | $14,000 | $7,267 | 51.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 21 | 21 | $2,100 | $1,330 | 63.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,800 | $1,225 | 25.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,600 | $949.23 | 26.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 60 | 60 | $1,500 | $882.60 | 58.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 59 | 103 | $3,605 | $858.42 | 23.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 31 | 31 | $2,015 | $638.91 | 31.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 70 | 162 | $3,240 | $520.02 | 16.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 47 | $1,645 | $447.44 | 27.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,650 | $380.82 | 23.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 19 | $950.00 | $308.18 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 32 | $640.00 | $268.80 | 42.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 27 | $918.00 | $205.47 | 22.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 22 | $990.00 | $174.61 | 17.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 26 | 125 | $2,500 | $48.19 | 1.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 20 | $400.00 | $44.00 | 11.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 20 | 94 | $470.00 | $39.45 | 8.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 26 | 270 | $540.00 | $22.64 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 286 | $53,790 | $20,502 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 341 | $45,050 | $16,648 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $13,800 | $7,418 | 53.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 49 | 49 | $4,900 | $3,329 | 67.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 21 | 21 | $5,250 | $1,831 | 34.9% |
About Jan Pixton, PAC
Jan Pixton, PAC is a Physician Assistant healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497828511.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jan Pixton, PAC has received a total of $8,814 in payments from pharmaceutical and medical device companies, with $2,281 received in 2024. These payments were reported across 568 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,811).
As a Medicare-enrolled provider, Pixton has provided services to 4,271 Medicare beneficiaries, totaling 10,051 services with total Medicare billing of $248,212. Data is available for 4 years (2020–2023), covering 89 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Wilmington, NC
- Active Since 11/16/2006
- Last Updated 08/29/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1497828511
Products in Payments
- FARXIGA (Drug) $821.41
- JARDIANCE (Drug) $787.42
- HETLIOZ (Drug) $606.11
- VRAYLAR (Drug) $490.81
- Kerendia (Drug) $394.46
- CAPLYTA (Drug) $351.24
- Ozempic (Drug) $319.21
- BREZTRI (Drug) $308.17
- Dayvigo (Drug) $253.85
- LINZESS (Drug) $192.56
- AIRSUPRA (Drug) $182.10
- CREON (Drug) $180.29
- XIFAXAN (Drug) $176.59
- Rybelsus (Drug) $174.82
- MOUNJARO (Drug) $168.89
- QULIPTA (Drug) $167.89
- TRELEGY ELLIPTA (Drug) $163.93
- BELSOMRA (Drug) $153.77
- UBRELVY (Drug) $138.82
- Wegovy (Drug) $130.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Wilmington
Mrs. Wendy Simmons, Pa, PA
Physician Assistant — Payments: $332,915
Physician Assistant $332,915
Karie Prokop, Pa-C, PA-C
Physician Assistant — Payments: $63,189
Physician Assistant $63,189
Mrs. Amy Burger, Pa, PA
Physician Assistant — Payments: $12,539
Physician Assistant $12,539
Elizabeth Benfield, P.a, P.A
Physician Assistant — Payments: $10,487
Physician Assistant $10,487
Mr. Lawrence Landrigan, Pa-C, PA-C
Physician Assistant — Payments: $10,244
Physician Assistant $10,244
Lindsey Lawrence, Pa-C, PA-C
Physician Assistant — Payments: $7,888
Physician Assistant $7,888